Recommendations for SCS in a Patient with MoCA 24
For a patient with MoCA 24 who demonstrates functional capacity through complex daily activities, proceed with SCS but implement enhanced informed consent procedures, structured post-operative monitoring protocols, and ensure robust caregiver involvement throughout the treatment course.
Cognitive Assessment Context
A MoCA score of 24 indicates mild cognitive impairment (below the typical cutoff of 26), though this patient's preserved ability to manage complex instrumental activities of daily living (paying bills, caregiving) suggests functional cognitive reserve 1, 2. The discordance between test score and functional performance is clinically significant—functional capacity should weigh more heavily than isolated screening scores in procedural decision-making 1.
Key Recommendations for the Pain Clinic
Pre-Procedural Requirements
Enhanced informed consent process:
- Conduct consent discussions over multiple sessions rather than a single encounter
- Include the patient's spouse or designated caregiver in all consent discussions
- Document the patient's understanding of: device function, trial period expectations, permanent implant commitment, need for ongoing programming adjustments, and potential complications
- Consider video-recording consent discussions (with permission) for future reference 1, 3
Psychosocial evaluation is mandatory:
- Screen specifically for: unrealistic expectations, inadequate daily activity level, problematic social support, psychological distress, and unwillingness to reduce opioids if applicable
- These factors are critical determinants of SCS success independent of cognitive status 1
- Assess the patient's ability to operate the programmer device and report complications appropriately 4, 3
Trial Period Modifications
Extend and structure the trial period:
- Use a longer trial period (10-14 days minimum rather than 5-7 days) to better assess the patient's ability to manage the device 3
- Require daily check-ins during trial (phone or in-person) to monitor for complications the patient may not spontaneously report
- Have caregiver document pain scores and functional changes independently 5
- Assess the patient's ability to: recognize and report lead migration symptoms, operate the controller appropriately, and follow activity restrictions 4
Post-Implantation Management
Structured follow-up protocol:
- Schedule more frequent follow-up visits in the first 6 months (every 2-4 weeks rather than standard 6-8 weeks) 3
- Establish a designated caregiver contact who can report concerns
- Provide written instructions with visual aids for device operation and complication recognition
- Create a simplified "red flag" symptom checklist for the patient and caregiver 4, 5
Complication surveillance:
- Patients with cognitive impairment may not recognize or report: infection signs, lead migration, battery depletion, or programming issues
- Lower threshold for imaging if pain relief diminishes or new symptoms emerge 4, 3
Clinical and Psychosocial Selection Criteria
This patient appears appropriate for SCS based on:
- Functional independence in complex tasks demonstrates adequate cognitive reserve for device management
- Active caregiving role suggests motivation and social support structure
- Ability to manage finances indicates executive function sufficient for treatment adherence 1
Critical exclusion factors to rule out:
- Lack of engagement or dysfunctional coping mechanisms
- Unrealistic expectations about pain relief (expecting 100% relief rather than 50-70% improvement)
- Inadequate social support despite spouse presence
- Secondary gain issues
- Unwillingness to participate in ongoing device management 1
Evidence Quality Considerations
The 2020 European consensus using RAND/UCLA methodology provides the strongest guidance on patient selection, emphasizing that psychosocial factors are equally important as clinical pain characteristics 1. While no guidelines specifically address cognitive impairment thresholds, the consensus emphasizes functional capacity over test scores 1, 3, 5.
Common Pitfalls to Avoid
- Do not rely solely on MoCA score—functional performance is more predictive of procedural success
- Do not proceed without caregiver involvement—even mild cognitive impairment requires support systems
- Do not use standard consent procedures—enhanced consent protects both patient and provider
- Do not assume the patient will self-report complications—proactive monitoring is essential
The combination of preserved functional capacity with documented mild cognitive impairment requires a modified approach to SCS implementation, not exclusion from therapy 1, 4, 3, 5.